Cancer Immunotherapy

Impacting All Cancers

From the preventive vaccine for cervical cancer to the first therapy ever proven to extend the lives of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a number of cancers. Every cancer type is unique, though, and immunology and immunotherapy are impacting each cancer in different ways.

The pages below provide brief statistics on each cancer, information on current unmet needs and treatment challenges, and an overview of the current and potential impact of immunotherapy for that cancer. Each page has been reviewed and verified by a dedicated expert in cancer immunotherapy.

Pages for additional cancer types—including cervical and other HPV-related cancers, leukemia, lymphoma, liver cancer, multiple myeloma, sarcoma, and other cancers—will be added shortly.

Wear White For A Cure

Join CRI and others in the support for cancer immunotherapy research by wearing white every Friday throughout the month of June.

Fight With White

Cancer Immunotherapy Clinical Trial Finder

Cancer Immunotherapy Clinical Trial Finder

Are you a patient interested in enrolling in a cancer immunotherapy clinical trial? Visit our Clinical Trial Finder page or call us at 1-855-216-0127, Monday through Friday from 8:30 a.m. to 6:00 p.m. ET, to see what clinical trials you may be eligible for.

Learn More

CRI Clinical Investigator Ian Frazer Creates HPV Vaccine That Prevents Cervical Cancer

Ian Frazer, AC, FRS, FAA

Dr. Ian Frazer is modest about his contribution to the development of the recently-announced breakthrough cervical cancer vaccine.

Learn More